Bramante Biologics (YC X25)
Bramante Biologics develops and manufactures AI-designed protein therapeutics for pharmaceutical and biotech customers. The company combines machine learning–driven protein design with contract development and manufacturing (CDMO) capabilities to take engineered proteins from in silico design through downstream bioprocessing to therapeutic-grade production. Its core technologies include computational protein engineering, AI-guided sequence optimization, and GMP bioprocessing for proteins. Bramante operates as a B2B service provider to biopharma firms seeking protein therapeutic development and manufacturing support.
Bramante Biologics (YC X25)
Bramante Biologics develops and manufactures AI-designed protein therapeutics for pharmaceutical and biotech customers. The company combines machine learning–driven protein design with contract development and manufacturing (CDMO) capabilities to take engineered proteins from in silico design through downstream bioprocessing to therapeutic-grade production. Its core technologies include computational protein engineering, AI-guided sequence optimization, and GMP bioprocessing for proteins. Bramante operates as a B2B service provider to biopharma firms seeking protein therapeutic development and manufacturing support.